» Articles » PMID: 27571990

Clinicopathological Features and Treatment Analysis of Rare Aggressive Angiomyxoma of the Female Pelvis and Perineum - a Retrospective Study

Overview
Specialty Oncology
Date 2016 Aug 31
PMID 27571990
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The study was to evaluate the clinicopathological features of aggressive angiomyxoma (AAM) of the female pelvis and perineum and its treatments. This was a retrospective study of female patients with AAM admitted to our hospital. Clinical and pathological data were analyzed, as well as the postsurgical follow-up. Median age at initial presentation was 41 years. Thirteen patients had lesions involving adjacent organs. Eighteen patients underwent complete tumor resection, while one patient underwent partial tumor resection. The tumors were soft in texture, pink in color, and had mucus on the surface. A microscopic examination revealed that the tumors were non-encapsulated, with spindle cells and stellate cells of almost identical size loosely distributed in the myxoid stroma, and vessels of different sizes and wall thicknesses. Immunohistochemistry indicated that AAMs were strongly positive for CD34 and smooth muscle actin, moderately positive for desmin, estrogen receptors and progesterone receptor, and mostly negative for S-100. After a median follow-up of 24 months, the recurrence rate was 33.3 %. Four recurrences were in patients with positive initial margins. AAM is a slow growing, locally invasive, benign tumor. Complete resection could lead to lower recurrence rate compared with incomplete resection. Follow-up is necessary for recurrent cases with repeated surgeries. The overall prognosis could be favorable.

Citing Articles

Imaging features of a rare giant intra-abdominal aggressive angiomyxoma.

Tuan T, Trang B, Chau N, Duy N, Anh N, Hung N Radiol Case Rep. 2024; 19(9):4007-4011.

PMID: 39044857 PMC: 11263912. DOI: 10.1016/j.radcr.2024.06.041.


Misleading clinical and imaging features in atypical aggressive angiomyxoma of the female vulvovaginal or perianal region: report of three cases and review of the literature.

Zhang L, Liu R, Peng J Front Oncol. 2024; 14:1373607.

PMID: 38590660 PMC: 10999629. DOI: 10.3389/fonc.2024.1373607.


Aggressive angiomyxoma in pregnancy: a case report and literature review.

Xu H, Sun P, Xu R, Wang L, Shi Y J Int Med Res. 2020; 48(7):300060520936414.

PMID: 32644864 PMC: 7350053. DOI: 10.1177/0300060520936414.


Application of ultrasound in aggressive angiomyxoma: Eight case reports and review of literature.

Zhao C, Su N, Jiang Y, Yang M World J Clin Cases. 2018; 6(14):811-819.

PMID: 30510948 PMC: 6264985. DOI: 10.12998/wjcc.v6.i14.811.


Transperineal aggressive angiomyxoma.

Pereira P, Melo Abreu E, Cunha T, Rolim I BMJ Case Rep. 2017; 2017.

PMID: 28400400 PMC: 5534792. DOI: 10.1136/bcr-2016-217705.

References
1.
Behranwala K, Thomas J . 'Aggressive' angiomyxoma: a distinct clinical entity. Eur J Surg Oncol. 2003; 29(7):559-63. DOI: 10.1016/s0748-7983(03)00104-5. View

2.
McCluggage W, Jamieson T, Dobbs S, Grey A . Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy. Gynecol Oncol. 2005; 100(3):623-5. DOI: 10.1016/j.ygyno.2005.09.033. View

3.
Baruah S, Latthe P, Bhatti N, Ghataura S . Aggressive angiomyxoma of the vulva. Hosp Med. 2004; 65(4):248-9. DOI: 10.12968/hosp.2004.65.4.12744. View

4.
Amezcua C, Begley S, Mata N, Felix J, Ballard C . Aggressive angiomyxoma of the female genital tract: a clinicopathologic and immunohistochemical study of 12 cases. Int J Gynecol Cancer. 2005; 15(1):140-5. DOI: 10.1111/j.1048-891x.2005.15015.x. View

5.
Outwater E, Marchetto B, Wagner B, Siegelman E . Aggressive angiomyxoma: findings on CT and MR imaging. AJR Am J Roentgenol. 1999; 172(2):435-8. DOI: 10.2214/ajr.172.2.9930798. View